Evidence map›Paper›PMID 30073201›Full record

ArticleeNeuro

Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery.

Karissa E Cottier, Emily A Galloway, Elisa C Calabrese, Margaret E Tome, Erika Liktor-Busa, John Kim, Thomas P Davis, Todd W Vanderah, Tally M Largent-Milnes

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Role of TNFPain research & management · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role of Neuroinflammation and Blood-Brain Barrier Permutability on Migraine.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Karissa E CottierDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Emily A GallowayDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Elisa C CalabreseDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Margaret E TomeDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Erika Liktor-BusaDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
John KimDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Thomas P DavisDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Todd W VanderahDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
Tally M Largent-MilnesDepartment of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ 85724.
University of Arizona · US

Funding

BLOOD TO CNS UPTAKE OF OPIOID PEPTIDE DRUGSR01DA011271 · NIDA · UNIVERSITY OF ARIZONA · PI DAVIS, THOMAS PAUL · 1997 to 2014
$4.4M
Blood Brain Barrier and Migraine: Effect on Therapy (Diversity Supplement)R01NS099292 · NINDS · UNIVERSITY OF ARIZONA · PI MILNES, TALLY MARIE · 2017 to 2021
$1.7M
NIDA NIH HHS R01 DA011271NINDS NIH HHS R01 NS099292
6 · The paper itself

Abstract

Cortical spreading depression (CSD) in the CNS is suggested as a common mechanism contributing to headache. Despite strong evidence for CNS involvement in headache disorders, drug development for headache disorders remains focused on peripheral targets. Difficulty in delivering drugs across the blood-brain barrier (BBB) may partially account for this disparity. It is known, however, that BBB permeability is increased during several CNS pathologies. In this study, we investigated BBB changes in response to KCl-induced CSD events and subsequent allodynia in rats. Cortical KCl injection in awake, freely moving rats produced facial allodynia with peak intensity between 1.5 and 3 h and CSD induction within 0.5-2 h postinjection. Brain perfusion of

Indexed as

AnimalsBlood-Brain BarrierBrain StemCentral Nervous System AgentsCerebral CortexCortical Spreading DepressionDisease Models, AnimalFemaleHeadacheHyperalgesiaPotassium ChlorideRatsRats, Sprague-DawleySumatriptanTopiramateCentral Nervous System AgentsPotassium ChlorideSumatriptanTopiramateblood-brain barrierCNScortical spreading depressiondrug deliveryheadachetriptan

Identifiers

PMID30073201
PMCPMC6071204
OpenAlexW2831151184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.